<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-one patients with <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0005558'>chronic leukemia</z:hpo> or severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were studied for NK activity against a <z:hpo ids='HP_0100522'>thymoma</z:hpo> cell line (Thy 121) before and after allogeneic bone marrow transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>The means of the pretransplant and post-transplant levels did not differ from the mean of 134 NK determinations in 67 healthy donors </plain></SENT>
<SENT sid="2" pm="."><plain>There was no correlation between pretransplant NK levels and the appearance of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Three weeks following bone marrow transplantation, pretransplant NK levels were observed </plain></SENT>
<SENT sid="4" pm="."><plain>The sensitivity of NK cells to interferon was the same as in <z:mpath ids='MPATH_458'>normal</z:mpath> donors both before and after bone marrow transplantation </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast to <z:chebi fb="0" ids="44185">methotrexate</z:chebi>, <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> inhibited NK activity in patients and controls in vitro </plain></SENT>
<SENT sid="6" pm="."><plain>In vivo <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> treatment, however, did not decrease NK levels in bone marrow recipients </plain></SENT>
</text></document>